Anastasios Dimou

10PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 27, 2026
Real-World Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Treatment Delivery, Immune Reconstitution, and Cardiac Monitoring During High-Dose IL-2.

|Apr 15, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial.

Matthew S Block, Garth D Nelson, Jun Chen

|Feb 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.

Tina J Hieken, Garth D Nelson, Thomas J Flotte

|Jan 26, 2024
Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing Panels.

Yiqing Zhao, Anastasios Dimou, Zachary C Fogarty

|Sep 27, 2023
Time to Think about HLA-Based Diagnostics in Lung Cancer?

Anastasios Dimou

|Mar 06, 2023
TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors.

Misako Nagasaka, Yuichiro Ohe, Caicun Zhou

Pageof 2

Frequent Collaborators

2 joint publications

Robert R McWilliams

2 joint publications

Heather N Montane

2 joint publications

Jane Yuet Ching Hui

2 joint publications

Lu Yang